Showing 64,841 - 64,860 results of 122,045 for search '(( 2 d decrease ) OR ( 5 ((wt decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 2.09s Refine Results
  1. 64841

    Basic characteristics of included studies. by Lipeng Shi (11307700)

    Published 2023
    “…The Cochrane Risk of Bias tool was utilized for RCTs’ methodological evaluation, while Review Manager 5.4.1 was used to analyze the data.</p><p>Results</p><p>Nineteen RCTs with a total of 1,911 patients (1,077 males and 834 females) were identified. …”
  2. 64842

    Forest plot of LVESD. by Lipeng Shi (11307700)

    Published 2023
    “…The Cochrane Risk of Bias tool was utilized for RCTs’ methodological evaluation, while Review Manager 5.4.1 was used to analyze the data.</p><p>Results</p><p>Nineteen RCTs with a total of 1,911 patients (1,077 males and 834 females) were identified. …”
  3. 64843

    Forest plot of clinical efficacy rate. by Lipeng Shi (11307700)

    Published 2023
    “…The Cochrane Risk of Bias tool was utilized for RCTs’ methodological evaluation, while Review Manager 5.4.1 was used to analyze the data.</p><p>Results</p><p>Nineteen RCTs with a total of 1,911 patients (1,077 males and 834 females) were identified. …”
  4. 64844

    Whole body mean fluorescence intensity (MFI) values of <i>Anopheles gambiae</i> females orally challenged with negatively charged 200 nm x 200 nm hydrogel particles for 1 and 2 day... by Cynthia C. H. Paquette (742621)

    Published 2015
    “…<p>MFI values for females orally challenged for 1 d with NPs were low compared to MFI values for females orally challenged for 2 d in which MFI values increased and peaked at approximately 3 d post challenge and decreased thereafter. …”
  5. 64845

    The model of RDV activating the autophagy pathway by obstructing SMARCB1 entry into the nucleus. by Hui Wang (30400)

    Published 2025
    “…NcSMARCB1 has a dual function in decreasing the transcription level of ATG5 by binding the ATG5 promoter and inhibiting the NcMYC’ ability to bind to promoter of ATG5 and ATG8, thus disrupting the autophagy activation. …”
  6. 64846

    Forest plot of TCM syndrome score efficacy. by Lipeng Shi (11307700)

    Published 2023
    “…The Cochrane Risk of Bias tool was utilized for RCTs’ methodological evaluation, while Review Manager 5.4.1 was used to analyze the data.</p><p>Results</p><p>Nineteen RCTs with a total of 1,911 patients (1,077 males and 834 females) were identified. …”
  7. 64847
  8. 64848

    Task structure and questions. by Niccolò Butti (8304798)

    Published 2024
    “…<div><p>Unmyelinated C-Tactile (CT) fibres are activated by caress-like touch, eliciting a pleasant feeling that decreases for static and faster stroking. …”
  9. 64849

    Supplementary Material for: Phosphate Binding Reduces Aortic Angiotensin-Converting Enzyme and Enhances Nitric Oxide Bioactivity in Experimental Renal Insufficiency by Eräranta A. (4132426)

    Published 2014
    “…<b><i>Methods:</i></b> Fifteen weeks after 5/6 nephrectomy<b> </b>(NX), rats were placed on a phosphate-binding (NX+Ca, 3.0% Ca), phosphate-loading (NX+Pi, 1.5% Pi), or control diet for 12 weeks (NX and sham). …”
  10. 64850
  11. 64851

    Image_2_Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24highCD38high Regulatory B Cells and Lower Levels of IL-10 Expression Compared to Responders.jpeg by Nina Körber (469767)

    Published 2021
    “…</p>Method<p>We performed comparative phenotypic and frequency analysis of Breg subsets (CD24<sup>+</sup>CD27<sup>+</sup> and CD24<sup>high</sup>CD38<sup>high</sup> Breg) in second-generation hepatitis B vaccine non-responders (2<sup>nd</sup> HBvac NR, n = 11) and responders (2<sup>nd</sup> HBvac R, n = 8) before (d0), on day 7 (d7), and 28 (d28) after booster vaccination. …”
  12. 64852

    Table_1_Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.DOCX by Prajwal Boddu (5780843)

    Published 2018
    “…Three and one complete responses were observed at dose-levels “0” and “1,” respectively; the overall response rate (ORR) was 36% (4 of 11 patients). A ≥ 50% decrease in CXCR4 mean fluorescence intensity was observed in 4 of 9 patients by flow cytometry, indicating incomplete suppression of CXCR4-receptor occupancy.…”
  13. 64853

    Table_1_Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.DOCX by Prajwal Boddu (5780843)

    Published 2018
    “…Three and one complete responses were observed at dose-levels “0” and “1,” respectively; the overall response rate (ORR) was 36% (4 of 11 patients). A ≥ 50% decrease in CXCR4 mean fluorescence intensity was observed in 4 of 9 patients by flow cytometry, indicating incomplete suppression of CXCR4-receptor occupancy.…”
  14. 64854
  15. 64855
  16. 64856
  17. 64857
  18. 64858
  19. 64859
  20. 64860